Eltrojas 50mg Tablet

About

Eltrojas 50mg Tablet is a thrombopoietin receptor agonist indicated for the treatment of chronic immune (idiopathic) thrombocytopenia (ITP) in patients who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. It works by stimulating the proliferation and differentiation of megakaryocytes, the bone marrow cells responsible for producing platelets, thereby increasing platelet counts. This oral medication helps to reduce the risk of bleeding events associated with low platelet levels. Eltrojas offers a non-invasive treatment option for managing ITP, aiming to maintain platelet counts above a critical threshold to prevent clinically significant hemorrhage. It represents a crucial therapeutic advancement for patients seeking to manage their condition effectively and improve their quality of life by reducing the frequency and severity of bleeding episodes.

Uses

• Treatment of chronic immune thrombocytopenia (ITP).
• Management of severe aplastic anemia.
• Prevention of bleeding in thrombocytopenic patients.
• Increasing platelet counts in specific hematologic disorders.

Directions For Use

Take orally once daily on an empty stomach, at least one hour before or two hours after meals.

Benefits

• Increases platelet counts effectively.
• Reduces the risk of bleeding.
• Offers an oral treatment option.
• Improves quality of life for ITP patients.
• Reduces need for rescue therapies.
• Provides long-term management for chronic ITP.

Side Effects

• Nausea
• Diarrhea
• Upper respiratory tract infection
• Fatigue
• Headache
• Muscle pain
• Joint pain
• Abdominal pain
• Increased liver enzymes
• Thromboembolic events (blood clots)
• Cataracts
• Bone marrow fibrosis

Safety Measures

• Alcohol - Alcohol should be consumed in moderation as it may increase the risk of bleeding or liver toxicity.
• Pregnancy - Not recommended during pregnancy due to potential fetal harm. Use effective contraception.
• Breastfeeding - Avoid breastfeeding as the drug may pass into breast milk and harm the infant.
• Liver - Use with caution in patients with pre-existing liver conditions. Monitor liver function tests regularly.
• Kidney - Dose adjustment may be necessary in severe renal impairment. Monitor kidney function.
• Lung - No specific contraindications, but monitor for any signs of pulmonary embolism.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.